Longitudinal MR imaging of iron in multiple sclerosis: An imaging marker of disease

Radiology

Volumn 270, Issue 1, 2014, Pages 186-196

  Walsh, Andrew J ^a   Blevins, Gregg ^a   Lebel, R Marc ^a   Seres, Peter ^a   Emery, Derek J ^a   Wilman, Alan H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN MAPPING; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULVINAR; QUANTITATIVE DIAGNOSIS; SUBSTANTIA NIGRA; THALAMUS;

ADULT; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84891131862     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130474     Document Type: Article

References (39)

1. Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120(1):7-25.
2. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134(pt 12):3602-3615.
3. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77(18):1691- 1697.
4. Lebel RM, Eissa A, Seres P, Blevins G, Wilman AH. Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 2012;18(4):433-441.
5. Zhang Y, Zabad RK, Wei X, Metz LM, Hill MD, Mitchell JR. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007;13(7):880-883.
6. Benarroch EE. Brain iron homeostasis and neurodegenerative disease. Neurology 2009; 72(16):1436-1440.
7. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3(1):41-51.
8. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987;149(2):357-363.
9. Meguro R, Asano Y, Odagiri S, Li C, Shoumura K. Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain: a light and electron microscopic study by the perfusion-Perls and -Turnbull methods. Arch Histol Cytol 2008; 71(4):205-222.
10. Miki Y, Grossman RI, Udupa JK, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images-lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213(2): 395-399.
11. Kappos L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999;353:964-969.
12. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346(3):158-164.
13. Rudick RA, Lee JC, Simon J, Fisher E. Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study. Ann Neurol 2006; 60(2):236-242.
14. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210(3):759-767.
15. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005 23(1):1-25.
16. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17(8):1141-1148.
17. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64(6):707-713.
18. Brass SD, Benedict RHB, Weinstock-Guttman B, Munschauer F, Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12(4):437-444.
19. Neema M, Arora A, Healy BC, et al. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 2009;19(1):3-8.
20. Zhang Y, Metz LM, Yong VW, Mitchell JR. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study. J Neurol Sci 2010;297(1-2):76-81.
21. Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62(9):1371-1376.
22. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010; 257(2):455-462.
23. Walsh AJ, Lebel RM, Eissa A, et al. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology 2013;267(2):531-542.
24. Peters AM, Brookes MJ, Hoogenraad FG, et al. T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 2007;25(6):748-753.
25. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58(6):840-846.
26. Du YPP, Jin ZY, Hu YZ, Tanabe J. Multiecho acquisition of MR angiography and venography of the brain at 3 Tesla. J Magn Reson Imaging 2009;30(2):449-454.
27. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52(3):612-618.
28. Walsh AJ, Eissa A, Blevins G, Wilman AH. Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering. J Magn Reson Imaging 2012;36(6):1460-1469.
29. Rasband WS. ImageJ. Bethesda, Md: U.S. National Institutes of Health, 1997-2011.
30. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005;64(7):1144-1151.
31. Cheah JH, Kim SF, Hester LD, et al. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006;51(4):431-440.
32. Walsh AJ, Wilman AH. Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter. Neuroimage 2011; 57(2):452-461.
33. Schäfer A, Wharton S, Gowland P, Bowtell R. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. Neuroimage 2009; 48(1):126-137.
34. Du YP, Chu R, Hwang D, et al. Fast multislice mapping of the myelin water fraction using multicompartment analysis of T2* decay at 3T: a preliminary postmortem study. Magn Reson Med 2007;58(5):865-870.
35. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32(6):749-763.
36. Sati P, van Gelderen P, Silva AC, et al. Micro-compartment specific T2* relaxation in the brain. Neuroimage 2013;77:268-278.
37. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127(Pt 5): 1101-1107.
38. Bendfeldt K, Hofstetter L, Kuster P, et al. Longitudinal gray matter changes in multiple sclerosis-differential scanner and overall disease-related effects. Hum Brain Mapp 2012;33(5):1225-1245.
39. Rooney WD, Johnson G, Li X, et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med 2007;57(2):308-318.